The European ME Research Group (EMERG) Consortium

DISCOVER-ME is delivered by a European ME Research Group (EMERG)-led consortium of 21 partner institutions across 12 European and international countries, working together to find reliable, evidence-based ways to diagnose and understand myalgic encephalomyelitis (ME or ME/CFS).

The consortium is coordinated by the Medical University of Vienna (MUVienna). Together, the consortium brings clinical, biomedical, and patient-engagement expertise to advance the understanding, diagnosis, and treatment of ME/CFS.

EMERG Consortium map

“Great discoveries and improvements invariably involve the cooperation of many minds.”
– Alexander Graham Bell

Consortium Partners

Coordinator

Medical University of Vienna (MUW), Austria

Quadram Institute Bioscience (QIB), UK

Stichting Amsterdam UMC, Netherlands

Aarhus Universitet, Denmark

Cardiff University UK

Centre National de la Recherche Scientifique France

GMBH Delta 4 GmbH Austria

European ME Alliance EMEA Sweden

FH Joanneum Gesellschaft mbH Austria

Foundation for Research and Technology Hellas (FORTH) Greece

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)

Fundación Universidad Católica de Valencia (UCV)

Imperial College London, UK

Institute for Cardiovascular Diseases “Dedinje” (IKVBD)

Landspitali University Hospital (LUH), Iceland

London School of Hygiene and Tropical Medicine (LSHTM), UK

Remedical loogo — ReMEdical ME ApS, Denmark

Université de Toulouse (affiliated entity under CNRS), France

Uppsala Universitet, Sweden

University of Galway, Ireland

University of Western Ontario (UWO), Canada